MoneyWorks4Me

Glenmark Pharmaceuticals informs about press release

28 Jun 2022 Evaluate

Glenmark Pharmaceuticals has informed that it attached a press release today titled ‘Glenmark Pharmaceuticals Inc., USA continues to expand its Over-The-Counter (OTC) Portfolio with the acquisition of approved ANDAs from Wockhardt Limited’.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1783.25
Dr. Reddys Labs. 1202.40
Cipla 1329.50
Lupin 2007.10
Zydus Lifesciences 1154.00
View more..